Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
3
×
boston blog main
gilead sciences
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
m&a
national
novartis
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
acquisition
adaptimmune
akouos
allogeneic
alnylam
What
acquisitions
airport
announced
annual
apocalypse
approved
beds
bio
celgene
ceo
collabs
covid
daniel
data
days
deal
disease
drug
fallout
fatty
gilead
gilead’s
gone
help
home
horizon
intercept
introduce
ipo
j.p
jpm
known
liver
marketed
medicine
medicines
month
nash
new
nonalcoholic
Language
unset
Current search:
allergan
×
" gilead sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
